Aspira Pathlab & Diagnostics shareholding pattern

As of 07-2026, the promoter shareholding in Aspira Pathlab & Diagnostics stands at 18.39% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Aspira Pathlab & Diagnostics is 0% and 0% respectively.

The retail shareholding of the Aspira Pathlab & Diagnostics is 81.61%.

Changes in shareholding patterns of Aspira Pathlab & Diagnostics can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Aspira Pathlab & Diagnostics are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.